These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19472574)

  • 1. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors. Comparing the options for mild-to-moderate dementia.
    Conn DK;
    Geriatrics; 2001 Sep; 56(9):56-7. PubMed ID: 11582975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety].
    Richard E; van Gool WA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects and drugs for Alzheimer's disease].
    Schück S; Bentué-Ferrer D; Beaufils C; Polard E; Belliard S; Allain H
    Therapie; 1999; 54(2):237-42. PubMed ID: 10394260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of Alzheimer's disease].
    Andersen SE
    Ugeskr Laeger; 2006 Oct; 168(44):3833; author reply 3833. PubMed ID: 17131519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition-enhancing drugs in dementia: a guide to the near future.
    van Reekum R; Black SE; Conn D; Clarke D
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the efficacy of cholinesterase inhibitor drugs.
    Hopper P; Trotter C
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):86-7. PubMed ID: 12497561
    [No Abstract]   [Full Text] [Related]  

  • 15. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
    Kornhuber J
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):553-4. PubMed ID: 15472777
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
    Prasher VP; Fung N; Adams C
    Int J Geriatr Psychiatry; 2005 May; 20(5):496-7. PubMed ID: 15852458
    [No Abstract]   [Full Text] [Related]  

  • 19. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
    García-Díaz JD; Fraguas C; Garcimartín C
    Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs for Alzheimer disease.
    Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.